The latest quarterly R&D expense is $20.73 Million with a QoQ Growth of +3.86%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $20.73M.
$20.73M
$20.73 Million
Q2 FY2026 · 2026-06-30
+3.86%
vs. $19.96M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $20.73M | +3.86% | +53.29% |
| Q1 FY2026Period end 2026-03-31 | $19.96M | +15.04% | +29.13% |
| Q4 FY2025Period end 2025-12-31 | $17.35M | +15.50% | +27.03% |
| Q3 FY2025Period end 2025-09-30 | $15.02M | +11.08% | +17.79% |
| Q2 FY2025Period end 2025-06-30 | $13.52M | -12.51% | +13.92% |
| Q1 FY2025Period end 2025-03-31 | $15.46M | +13.17% | +59.59% |
| Q4 FY2024Period end 2024-12-31 | $13.66M | +7.10% | +20.35% |
| Q3 FY2024Period end 2024-09-30 | $12.75M | +7.43% | -2.33% |
| Q2 FY2024Period end 2024-06-30 | $11.87M | +22.57% | -10.21% |
| Q1 FY2024Period end 2024-03-31 | $9.68M | -14.66% | -29.35% |
| Q4 FY2023Period end 2023-12-31 | $11.35M | -13.08% | -28.68% |
| Q3 FY2023Period end 2023-09-30 | $13.06M | -1.23% | -24.81% |
| Q2 FY2023Period end 2023-06-30 | $13.22M | -3.56% | +3.70% |
| Q1 FY2023Period end 2023-03-31 | $13.71M | -13.86% | -1.58% |
| Q4 FY2022Period end 2022-12-31 | $15.91M | -8.37% | +217.35% |
| Q3 FY2022Period end 2022-09-30 | $17.36M | +36.23% | +132.03% |
| Q2 FY2022Period end 2022-06-30 | $12.75M | -8.47% | +70.05% |
| Q1 FY2022Period end 2022-03-31 | $13.93M | +177.76% | +100.85% |
| Q4 FY2021Period end 2021-12-31 | $5.01M | -33.00% | N/A |
| Q3 FY2021Period end 2021-09-30 | $7.48M | -0.16% | N/A |
| Q2 FY2021Period end 2021-06-30 | $7.50M | +8.10% | N/A |
| Q1 FY2021Period end 2021-03-31 | $6.93M | N/A | N/A |
| Q4 FY2020Period end 2021-01-31 | $5.52M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
